Day One Biopharmaceuticals, Inc.DDay One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc.

12,59USDC
−0,12−0,94%
Kapanışta Oca 3, 23:44 UTC
USD
İşlem yok
Süper-grafiklerde görün

DAWN temelleri

Gelir, giderler, kâr ve zarar dahil olmak üzere Day One Biopharmaceuticals, Inc. mali tabloları

DAWN'nin son çeyrekteki toplam geliri 93.76 M USD ve önceki çeyreğe göre 1044.54% daha yüksek. Q3 24 döneminin net geliri 37.04 M USD'dur.

Q1 '20
Q2 '20
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−120,00 M‬‬
‪‪−60,00 M‬‬
‪0,00‬
‪‪60,00 M‬‬
‪‪120,00 M‬‬
Toplam Gelir
Brüt Kar
Faaliyet gelirleri
Vergi öncesi gelir
Net gelir
Döviz: USD
Q1 '20
Mar 2020
Q2 '20
Haz 2020
Q3 '20
Eyl 2020
Q1 '21
Mar 2021
Q2 '21
Haz 2021
Q3 '21
Eyl 2021
Q4 '21
Ara 2021
Q1 '22
Mar 2022
Q2 '22
Haz 2022
Q3 '22
Eyl 2022
Q4 '22
Ara 2022
Q1 '23
Mar 2023
Q2 '23
Haz 2023
Q3 '23
Eyl 2023
Q4 '23
Ara 2023
Q1 '24
Mar 2024
Q2 '24
Haz 2024
Q3 '24
Eyl 2024
TTM
Toplam GelirYY büyüme
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪8,19 M‬‬
‪‪93,76 M‬‬
‪‪101,95 M‬‬
‪‪−180,00 K‬‬
‪‪−89,00 K‬‬
‪‪−92,00 K‬‬
‪‪−99,00 K‬‬
‪‪−103,00 K‬‬
‪‪−116,00 K‬‬
‪‪−707,00 K‬‬
‪‪−1,59 M‬‬
‪‪−2,52 M‬‬
Brüt KarYY büyüme
‪‪−180,00 K‬‬
−252,94%
‪‪−89,00 K‬‬
−1.383,33%
‪‪−92,00 K‬‬
+30,83%
‪‪−99,00 K‬‬
+40,00%
‪‪−103,00 K‬‬
+42,78%
‪‪−116,00 K‬‬
−30,34%
‪‪7,49 M‬‬
‪‪92,17 M‬‬
‪‪99,44 M‬‬
‪‪−42,56 M‬‬
‪‪−45,77 M‬‬
‪‪−49,16 M‬‬
‪‪−51,34 M‬‬
‪‪−59,41 M‬‬
‪‪−66,65 M‬‬
‪‪−122,29 M‬‬
‪‪−62,53 M‬‬
‪‪−310,89 M‬‬
‪‪−42,74 M‬‬
−94,51%
‪‪−45,85 M‬‬
−65,26%
‪‪−49,25 M‬‬
−34,14%
‪‪−51,44 M‬‬
−29,57%
‪‪−59,52 M‬‬
−39,24%
‪‪−66,77 M‬‬
−45,60%
‪‪−114,81 M‬‬
−133,09%
‪‪29,64 M‬‬
‪‪−211,46 M‬‬
‪‪2,63 M‬‬
‪‪3,46 M‬‬
‪‪3,39 M‬‬
‪‪5,29 M‬‬
‪‪5,01 M‬‬
‪‪4,36 M‬‬
‪‪111,95 M‬‬
‪‪6,52 M‬‬
‪‪127,83 M‬‬
‪‪−40,11 M‬‬
−82,83%
‪‪−42,39 M‬‬
−52,78%
‪‪−45,86 M‬‬
−25,55%
‪‪−46,15 M‬‬
−22,11%
‪‪−54,51 M‬‬
−35,91%
‪‪−62,41 M‬‬
−47,22%
‪‪−2,85 M‬‬
+93,77%
‪‪36,16 M‬‬
‪‪−83,62 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−1,55 M‬‬
‪‪882,00 K‬‬
‪‪−670,00 K‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−40,11 M‬‬
‪‪−42,39 M‬‬
‪‪−45,86 M‬‬
‪‪−46,15 M‬‬
‪‪−54,51 M‬‬
‪‪−62,41 M‬‬
‪‪−4,41 M‬‬
‪‪37,04 M‬‬
‪‪−84,29 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
Net gelirYY büyüme
‪‪−40,11 M‬‬
−82,83%
‪‪−42,39 M‬‬
−52,78%
‪‪−45,86 M‬‬
−25,55%
‪‪−46,15 M‬‬
−22,11%
‪‪−54,51 M‬‬
−35,91%
‪‪−62,41 M‬‬
−47,22%
‪‪−4,41 M‬‬
+90,39%
‪‪37,04 M‬‬
‪‪−84,29 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−40,11 M‬‬
‪‪−42,39 M‬‬
‪‪−45,86 M‬‬
‪‪−46,15 M‬‬
‪‪−54,51 M‬‬
‪‪−62,41 M‬‬
‪‪−4,41 M‬‬
‪‪37,04 M‬‬
‪‪−84,29 M‬‬
‪−0,55‬
−54,19%
‪−0,59‬
−23,92%
‪−0,61‬
−1,76%
‪−0,54‬
−0,86%
‪−0,62‬
−14,45%
‪−0,72‬
−22,24%
‪−0,05‬
+91,73%
‪0,38‬
‪−1,01‬
‪−0,55‬
−54,19%
‪−0,59‬
−23,92%
‪−0,61‬
−1,76%
‪−0,54‬
−0,86%
‪−0,62‬
−14,45%
‪−0,72‬
−22,24%
‪−0,05‬
+91,73%
‪0,38‬
‪−1,01‬
‪‪73,46 M‬‬
‪‪71,97 M‬‬
‪‪74,96 M‬‬
‪‪85,95 M‬‬
‪‪87,23 M‬‬
‪‪86,68 M‬‬
‪‪87,12 M‬‬
‪‪96,62 M‬‬
‪‪73,46 M‬‬
‪‪71,97 M‬‬
‪‪74,96 M‬‬
‪‪85,95 M‬‬
‪‪87,23 M‬‬
‪‪86,68 M‬‬
‪‪87,12 M‬‬
‪‪96,94 M‬‬
FAVÖKYY büyüme
‪‪−42,56 M‬‬
−94,14%
‪‪−45,77 M‬‬
−64,97%
‪‪−49,16 M‬‬
−34,37%
‪‪−51,34 M‬‬
−29,86%
‪‪−59,41 M‬‬
−39,59%
‪‪−66,65 M‬‬
−45,63%
‪‪−114,40 M‬‬
−132,70%
‪‪30,38 M‬‬
‪‪−210,08 M‬‬
FVÖKYY büyüme
‪‪−42,74 M‬‬
−94,51%
‪‪−45,85 M‬‬
−65,26%
‪‪−49,25 M‬‬
−34,14%
‪‪−51,44 M‬‬
−29,57%
‪‪−59,52 M‬‬
−39,24%
‪‪−66,77 M‬‬
−45,60%
‪‪−114,81 M‬‬
−133,09%
‪‪29,64 M‬‬
‪‪−211,46 M‬‬
‪‪−42,74 M‬‬
‪‪−45,85 M‬‬
‪‪−49,25 M‬‬
‪‪−51,44 M‬‬
‪‪−59,52 M‬‬
‪‪−66,77 M‬‬
‪‪−123,00 M‬‬
‪‪−64,13 M‬‬
‪‪−313,41 M‬‬